Cite
HARVARD Citation
Alnahhas, I. et al. (2021). Erratum to: Characterizing Benefit from Temozolomide in MGMT Promoter Unmethylated and Methylated Glioblastoma: A Systematic Review and Meta-analysis. Neuro-oncology advances. 3 (1), p. . [Online].